Figure 2
Average TMD symptom score (TSS) at baseline and after 3 and 6 months of occlusal splint therapy. P-values determined by the Friedman test and Conover post hoc test with a Holm–Bonferroni correction (*p < 0.05; **p < 0.0001; ***p < 0.00001).
Figure 2 | Scientific Reports
